Finance

Lists
Q3 2026 earnings • released • EPS beat +54.73% • Revenue beat +0.31%
See results
BLCO:NYSE
Bausch + Lomb Corp
$19.92
-2.45%
(-0.50) 1D
Oct 30, 2:58:14 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLCO...
Open
$20.85
High
$20.85
Low
$19.83
Mkt. cap
7.12B
Avg. vol.
715.72K
Volume
832.10K
52-wk high
$21.36
52-wk low
$14.44
EPS
-$0.31
Beta
0.56
Shares outstanding
357.50M
No. of employees
13K
Open
$20.85
High
$20.85
Low
$19.83
Mkt. cap
7.12B
Avg. vol.
715.72K
Volume
832.10K
52-wk high
$21.36
52-wk low
$14.44
EPS
-$0.31
Beta
0.56
Shares outstanding
357.50M
No. of employees
13K
News stories
From web sources and news partners
About Bausch + Lomb Corp
CEO-
Employees13K
Founded1853
HeadquartersVaughan, Ontario, Canada
SectorMedical device
Websitebausch.com
Analyst ratings
Based on 10 analysts giving stock ratings to BLCO in the past 3 months
Buy
Buy
5
Hold
4
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BLCO in the last 3 months.
Highest
Current $19.92
$26.00 (+30.52%)
Average
$21.78 (+9.34%)
Lowest
$18.00 (-9.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
$19.00
-4.6%
10/29/2026
Travis Steed
Bank of America Securities
Sell
Maintained
-
-
10/29/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
$20.00
+0.4%
10/29/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$22.00
+10.4%
10/29/2026
Daniel Clark
Leerink Partners
Buy
Reiterated
$26.00
+30.5%
10/29/2026
Douglas Miehm
RBC Capital
Buy
Reiterated
$23.00
+15.5%
10/29/2026
Joanne Wuensch
Citi
Buy
Maintained
$23.00
+15.5%
10/29/2026
Christopher Pasquale
Barclays
Buy
Initiated
$24.00
+20.5%
10/07/2026
Matt Miksic
Barclays
Buy
Maintained
$24.00
+20.5%
10/07/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$18.00
-9.6%
09/18/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$21.00
+5.4%
08/28/2026
Vijay Kumar
Evercore ISI
Hold
Maintained
$17.00
-14.7%
07/30/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
$18.00
-9.6%
07/30/2026
David Saxon
Needham
Hold
Maintained
-
-
07/29/2026
Unknown Analyst
UBS
Buy
Maintained
$23.00
+15.5%
07/30/2026
Patrick Wood
UBS
Buy
Initiated
$23.00
+15.5%
07/30/2026
David Roman
Goldman Sachs
Hold
Maintained
$21.00
+5.4%
07/14/2026
Last report
Oct 28, 2026
Fiscal period
Q3 2026
$0.34 / $0.22
+54.73%beat
Revenue / Est. (USD)
1.38B / 1.37B
+0.31%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.28B
1.40B
1.24B
1.39B
Cost of goods sold
510.00M
533.00M
483.00M
527.00M
Cost of revenue
510.00M
533.00M
483.00M
527.00M
Research and development expenses
95.00M
94.00M
101.00M
114.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
528.00M
564.00M
544.00M
588.00M
Operating expense
691.00M
714.00M
702.00M
759.00M
Total operating expenses
1.20B
1.25B
1.18B
1.29B
Operating income
80.00M
158.00M
59.00M
108.00M
Other non operating income
-
-
-1.00M
-
EBT including unusual items
-3.00M
13.00M
-64.00M
-11.00M
EBT excluding unusual items
-21.00M
59.00M
-37.00M
14.00M
Income tax expense
22.00M
71.00M
6.00M
-1.00M
Effective tax rate
-733.33%
546.15%
-9.38%
9.09%
Other operating expenses
-
-
-
-
Net income
-28.00M
-58.00M
-71.00M
-14.00M
Net profit margin
-2.19%
-4.13%
-5.71%
-1.00%
Earnings per share
0.18
0.32
0.08
0.16
Interest and investment income
3.00M
3.00M
4.00M
4.00M
Interest expense
-101.00M
-98.00M
-97.00M
-93.00M
Net interest expenses
-98.00M
-95.00M
-93.00M
-89.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
189.00M
257.00M
160.00M
210.00M
Gain or loss from assets sale
-6.00M
-
-3.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps